Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Nobuko Kawaguchi"'
Autor:
Tomoko Izawa, Ami Kobayashi, Masahiro Kawashima, Nobuko Kawaguchi-Sakita, Akiyoshi Nakakura, Yuki Kataoka, Kenichiro Shide, Yukiko Mori, Kazuhiro Yamazaki, Masakazu Toi, Harue Arao
Publikováno v:
BMC Women's Health, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background Systemic edema is an adverse effect of docetaxel chemotherapy and causes distress to patients, including those receiving this agent for breast cancer. However, its characteristics and factors related to its effect on quality of li
Externí odkaz:
https://doaj.org/article/4d957cfe23e84516a2c812352327800f
Autor:
Ayane Yamaguchi, Maya Honda, Hiroshi Ishiguro, Masako Kataoka, Tatsuki R. Kataoka, Hanako Shimizu, Masae Torii, Yukiko Mori, Nobuko Kawaguchi-Sakita, Kentaro Ueno, Masahiro Kawashima, Masahiro Takada, Eiji Suzuki, Yuji Nakamoto, Kosuke Kawaguchi, Masakazu Toi
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract This study aimed to evaluate the predictions of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for prognosis of triple-negative breast cancer (TNBC), especially with residual disease (RD) after preoperative chemotherapy. This
Externí odkaz:
https://doaj.org/article/50ca524a075a42ba86b159a9b55637d5
Autor:
Iku Yamaga, Nobuko Kawaguchi-Sakita, Yasufumi Asao, Yoshiaki Matsumoto, Aya Yoshikawa, Toshifumi Fukui, Masahiro Takada, Masako Kataoka, Masahiro Kawashima, Elham Fakhrejahani, Shotaro Kanao, Yoshie Nakayama, Mariko Tokiwa, Masae Torii, Takayuki Yagi, Takaki Sakurai, Hironori Haga, Kaori Togashi, Tsuyoshi Shiina, Masakazu Toi
Publikováno v:
Photoacoustics, Vol 11, Iss , Pp 6-13 (2018)
This study aimed to identify the characteristics of the vascular network in the superficial subcutaneous layer of the breast and to analyze differences between breasts with cancer and contralateral unaffected breasts using vessel branching points (VB
Externí odkaz:
https://doaj.org/article/329975420ed94677b09e92b54a1c2018
Autor:
Ichiro Yamauchi, Akihiro Yasoda, Shigemi Matsumoto, Yuichi Sakamori, Young Hak Kim, Motoo Nomura, Atsushi Otsuka, Toshinari Yamasaki, Ryoichi Saito, Morimasa Kitamura, Toshio Kitawaki, Masakatsu Hishizawa, Nobuko Kawaguchi-Sakita, Toshihito Fujii, Daisuke Taura, Masakatsu Sone, Nobuya Inagaki
Publikováno v:
PLoS ONE, Vol 14, Iss 5, p e0216954 (2019)
BackgroundBlocking the PD-1 pathway induces immune-related adverse events (irAEs) which often involve the thyroid gland (thyroid irAEs). Clinical features of a thyroid irAE including its predictability and relationship to prognosis remain to be eluci
Externí odkaz:
https://doaj.org/article/5af6610dbdcb437fa513957cc5348edd
Autor:
Nobuko Kawaguchi-Sakita, Noriko Senda, Yukiko Inagaki-Kawata, Hiromi Murakami, Sayaka Honda, Takahiro Yamada, Yuki Kataoka, Shoko Takahara, Shigeru Tsuyuki, Kazuhiko Yamagami, Yoshio Moriguchi, Masae Torii, Tatsushi Kato, Hirofumi Suwa, Wakako Tsuji, Eiji Suzuki, Akira Yamauchi, Ryuji Okamura, Shinji Kosugi, Masakazu Toi
Publikováno v:
Cancer Research. 83:P2-05
[Introduction] Personalized health care is recommended for the prevention and early detection of breast cancer. Advances in technology have made it possible to estimate genetic risk, PGV (pathogenic/likely-pathogenic germline variant) or PRS (polygen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::453971011d367876fdff63036c492ed5
https://doi.org/10.1158/1538-7445.sabcs22-p2-05-02
https://doi.org/10.1158/1538-7445.sabcs22-p2-05-02
Publikováno v:
Screening and Risk Reduction Strategies for Breast Cancer ISBN: 9789811976292
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cddda6a7b2b8db151aa25087ebab1dd8
https://doi.org/10.1007/978-981-19-7630-8_3
https://doi.org/10.1007/978-981-19-7630-8_3
Autor:
Kaori Togashi, Akira Yamauchi, Hironori Kato, Nobuhiko Shinkura, Kenichi Yoshida, Kosuke Kawaguchi, Takahiro Yamada, Ryuji Okamura, Masahiro Sugimoto, Eiji Suzuki, Hironori Haga, Masae Torii, Hirofumi Suwa, Norimichi Kan, Sachiko Takahara, Yoshiaki Matsumoto, Masahiro Kawashima, Tsuyoshi Tachibana, Masakazu Toi, Yukiko Inagaki-Kawata, Hiroshi Yoshibayashi, Takashi Inamoto, Masako Kataoka, Shingo Sakata, Nobuko Kawaguchi-Sakita, Fumiaki Yotsumoto, Kazuhiko Yamagami, Yuki Kataoka, Mitsuru Tanaka, Shinji Kosugi, Masahiro Takada, Seishi Ogawa, Shigeru Tsuyuki, Tomomi Nishimura, Susumu Mashima, Noriko Senda, Yoshio Moriguchi
Publikováno v:
Cancer Science
Predicting pathogenic germline variants (PGVs) in breast cancer patients is important for selecting optimal therapeutics and implementing risk reduction strategies. However, PGV risk factors and the performance of prediction methods in the Japanese p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21bafd3a7488cd234e791c5630dc4892
http://hdl.handle.net/2433/277559
http://hdl.handle.net/2433/277559
Publikováno v:
Annals of Pharmacotherapy. 56:245-255
Background Previous studies have suggested that metformin might improve survival outcomes in patients with breast cancer. However, findings on the efficacy of metformin with chemotherapy or endocrine therapy are inconsistent. Objective To clarify the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95e4c7a8c9692af6f3072f0d092c2a8f
https://doi.org/10.1177/10600280211025792
https://doi.org/10.1177/10600280211025792
Autor:
Takashi Inamoto, Fumiaki Yotsumoto, Masahiro Kawashima, Masae Torii, Hiroshi Yoshibayashi, Masakazu Toi, Akira Yamauchi, Kenichi Yoshida, Nobuko Kawaguchi-Sakita, Mitsuru Tanaka, Shingo Sakata, Masahiro Sugimoto, Hirofumi Suwa, Nobuhiko Shinkura, Shigeru Tsuyuki, Yukiko Inagaki-Kawata, Yuki Kataoka, Yoshiaki Matsumoto, Tomomi Nishimura, Norimichi Kan, K Yamagami, Ryuji Okamura, Susumu Mashima, Fumiaki Sato, Hironori Kato, Yoshio Moriguchi, Noriko Senda, Tsuyoshi Tachibana, Masahiro Takada, Seishi Ogawa, Eiji Suzuki
Publikováno v:
Cancer Research. 80:P2-10
Background: Breast cancer risk models are used to predict the risk of carrying a variant, for one of the most common breast cancer susceptibility genes such as BRCA1 and BRCA2, and the lifetime risk of developing breast cancer. The prediction of harb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ce4e60b1ede049cf36eba438eea22c5
https://doi.org/10.1158/1538-7445.sabcs19-p2-10-12
https://doi.org/10.1158/1538-7445.sabcs19-p2-10-12
Autor:
Sunao Tanaka, Masakazu Toi, Souichi Adachi, Natsuki Wariishi, Nobuko Kawaguchi-Sakita, Yasuhiko Kamikubo
Publikováno v:
Cancer Research. 80:P3-06
In breast cancer, both incidence and mortality have been increasing. Triple negative breast cancer (TNBC), one of breast cancer subtypes, is a heterogeneous nature that is negative for estrogen receptor (ER), progesterone receptor (PR) and human epit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f05897a91d748fc7f13302d5e360797a
https://doi.org/10.1158/1538-7445.sabcs19-p3-06-06
https://doi.org/10.1158/1538-7445.sabcs19-p3-06-06